Background
==========

Nuclear hormone receptors and transcription factors can regulate the transcription of their target genes by inducing chromatin changes. Paradigmatic are the retinoic acid receptor alpha (RARα) and the transcription factor core binding factor (CBF), which regulate in this way the transcription of target genes involved in hematopoietic processes \[[@B1],[@B2]\]. Differently from RARα, which epigenetically activates its targets by recruiting coactivator protein complexes with histone acetyl transferase (HAT) activity only when bound to retinoic acid, CBF can directly recruit HAT-containing complexes to activate its targets \[[@B3]-[@B6]\]. One of the two CBF subunits, CBFα or AML1, can bind target genes endowed with the AML1-consensus sequence TG(T/C)GGT via its N-terminal DNA-binding domain \[[@B7]\]. *AML1*, encoding a master hematopoietic transcription factor, is frequently affected by different chromosome translocations in leukemic cells \[[@B8]\]. Moreover, *AML1*haploinsufficiency was found to be associated with familial platelet disorder, a condition predisposing to acute myeloid leukemia \[[@B9]\].

Two leukemia-associated chromosome translocations, the t(8;21)(q22;q22) and the t(16;21)(q24;q22), result in the fusion between the N-terminal region of AML1 and the C-terminal regions of two almost identical chromatin corepressors, MTG8 and MTG16, leading to the formation of AML1-MTG8 and AML1-MTG16, respectively \[[@B10]-[@B13]\]. Upon fusion with either MTG8 or MTG16, AML1 is converted from a transcriptional activator into a transcriptional repressor of AML1-targets. Specific MTG domains in the wild type, as well as in the MTG fusion proteins, can interact, directly or via other corepressors such as NCoR and Sin3A, with histone deacetylases (HDACs), thus creating a repressive chromatin state at AML1 target sites (reviewed in \[[@B14],[@B15]\]). Repression at these sites is further enhanced by the formation of oligomers between the fusion proteins and wild-type MTG proteins \[[@B16]-[@B18]\].

Myeloid cell differentiation systems, such as the 32D mouse myeloid cell line, ectopically expressing either AML1-MTG8 or AML1-MTG16, were used as models to simulate some of the effects of these fusion proteins in myelogenesis and leukemogenesis. Both fusion proteins, when exogenously expressed in the 32D background, were shown to affect granulocytic differentiation and produce distinct effects on cell proliferation \[[@B19]-[@B21]\]. In a preliminary study, we found that AML1-MTG16, when exogenously expressed in 32D cells, can induce aberrant myeloid phenotypes in association with repressive modifications at the chromatin of the Colony stimulating factor 1 receptor (*Csf1r*), an AML1-target gene encoding the macrophage colony stimulating factor receptor \[[@B19]\]. Based on this finding, we hypothesize that the comparative epigenetic analysis of the changes induced by different AML1-MTG fusion proteins in an identical cell context (e.g. the 32D context) might provide a lead to elucidating the differences observed in leukemic cells carrying either one of the two proteins \[[@B8]\]. The objective of this study was to demonstrate whether AML1-MTG16 induces epigenetic changes at AML1-target genes in the 32D myeloid cell genome. Only by coupling global gene expression array analysis with a bioinformatic genomic survey for the AML1-consensus sequence, we were able to close onto AML1-targets downregulated by AML1-MTG16. AML1-MTG16-induced transcriptional downregulation was marked by the acquisition of a distinct repressive chromatin signature.

Results
=======

Global gene expression array analysis of AML1-MTG16-expressing cells
--------------------------------------------------------------------

To study the molecular and biological consequences of AML1-MTG16 expression in a myeloid differentiation cell model, we previously developed, by infecting 32D mouse myeloblasts with retroviral particles carrying either the pLNCX2 vector containing the AML1-MTG16 cDNA or the cognate empty vector, stable independent clones expressing AML1-MTG16 (hereafter called A16 clones) and stable independent control clones (hereafter called \"mock\" clones), respectively (Figure [1A](#F1){ref-type="fig"}). Upon treatment with granulocyte colony stimulating factor (G-CSF), A16 clones do not undergo granulocytic differentiation and proliferate significantly less than mock clones (Figure [1B](#F1){ref-type="fig"}). Global gene expression analysis (setting the p-value at \< 0.05 and the absolute fold change at \> 1.5) of a prototypic A16 clone and a prototypic mock clone grown either with interleukin 3 (IL-3) or G-CSF for 16 h, was combined with bioinformatic analysis of the proteins encoded by all the differentially expressed genes with the Ingenuity software (see Methods). This analysis clearly revealed a network comprising proteins critical for platelet function in A16 cells (see Additional file [1](#S1){ref-type="supplementary-material"}). The identification of this protein network strongly supports the biological data, indicating the occurrence of functional AML1 haploinsufficiency in A16 cells \[[@B9]\].

Further analysis of the gene expression data (setting the p-value at \< 0.01 and the absolute fold change at \> 3) enabled us to identify 138 differentially expressed genes, of which 66 differentially expressed genes in cells grown with IL-3, 67 differentially expressed genes in cells grown with G-CSF, and 5 differentially expressed genes in both cells grown with IL-3 and G-CSF (Figure [1C](#F1){ref-type="fig"}, left, and Table [1](#T1){ref-type="table"} and Table [2](#T2){ref-type="table"}). According to the Ingenuity software, the differentially expressed genes in A16 cells were mostly implicated in tumorigenesis, cell proliferation, and hematopoiesis (Figure [1C](#F1){ref-type="fig"}, right). Since from this analysis alone we were unable to conclude whether, or not, these genes were AML1-MTG16 direct targets, we devised a bioinformatic approach aimed at identifying the AML1-consensus sequence in the 10 Kb region around the transcription start site of these genes.

Identification of genes containing the AML1-consensus sequence by bioinformatic analysis
----------------------------------------------------------------------------------------

Since the AML1-MTG proteins have a transcriptionally repressive function (reviewed in \[[@B14]\]), we focused our bioinformatic analysis on the 37 genes downregulated by AML1-MTG16 (see genes in bold in Table [1](#T1){ref-type="table"} and Table [2](#T2){ref-type="table"}). Specifically, we searched the 10 Kb around the transcription start site of each gene for either the AML1-binding consensus sequence TG(T/C)GGT or, this sequence in reverse orientation, ACC(G/A)CA. With the MEME software (see Methods) we identified a conserved motif, hereafter called AML1-consensus motif (Figure [2A](#F2){ref-type="fig"}), encompassing the AML1-consensus sequence in seventeen out of the 37 genes (Figure [2B](#F2){ref-type="fig"} and Table [3](#T3){ref-type="table"}). We focused on five of these genes, *Fcer1a, Tcfec, Ptprcap, F2rl3*, and *Mgmt*(Figure [2B](#F2){ref-type="fig"}, right), because they were among the most significantly downregulated genes. *Fcer1a, Tcfec, Ptprcap, F2rl3*, and *Mgmt*encode for known proteins. Specifically, Fcer1a is the Fc fragment of IgE and is involved in the immune response \[[@B22]\]; Tcfec is a transcription factor that induces, among other genes, the G-CSF receptor gene \[[@B23],[@B24]\]; Ptprcap is a transmembrane protein associated with CD45, a key regulator of lymphocytes activation \[[@B25]\]; F2rl3 is a member of G protein-coupled protease-activated receptors (PARs) of the coagulation factor II (thrombin) and plays an important role in platelet activation \[[@B26]\]; Mgmt is a DNA repair enzyme that is frequently lost in cancer due to epigenetic silencing \[[@B27]\]. Downregulation of these genes was confirmed by real time RT-PCR (Figure [2C](#F2){ref-type="fig"}).

*Fcer1a, Tcfec, Ptprcap, F2rl3*, and *Mgmt*are direct AML1-MTG16 targets
------------------------------------------------------------------------

Quantitative chromatin immunoprecipitation (ChIP) with an anti-AML1 specific antibody, but not with an anti-MTG16 antibody (data not shown), showed significant (p \< 0.05) enrichment of the region encompassing the AML1-consensus motif (see bars in figure [3A](#F3){ref-type="fig"}, left) relative to an arbitrary control region without the AML1-consensus motif in the mock clone chromatin for all five genes, indicating endogenous AML1 binding at these regions (Figure [3B](#F3){ref-type="fig"}). ChIP with an anti-MTG16 antibody showed instead a significant enrichment of exogenous AML1-MTG16 in the same chromatin regions in the A16 clones (Figure [3B](#F3){ref-type="fig"}). The human homologues of these genes also contain an AML1-consensus sequence(s) in the 10Kb region surrounding the transcription start site, pointing to these five genes as novel, *bona fide*direct AML1-targets genes.

Repressive chromatin changes at AML1-MTG16-downregulated targets
----------------------------------------------------------------

We previously demonstrated that AML1-MTG16 interacts with both HDAC1 and HDAC3 \[[@B28]\]. Further, we found that AML1-MTG16 can induce downregulation marked by repressive histone hypoacetylation at the *Csf1r*chromatin \[[@B19]\]. Here we show that, in A16 cells, the chromatin associated with both the region containing the AML1-consensus motif and the region encompassing the transcription start site of *Fcer1a, Tcfec, Ptprcap, F2rl3*, and *Mgmt*(Figure [3A](#F3){ref-type="fig"}) displays a significant (p \< 0.05) decrease of acetylated histone H4 (Ac-H4), and a significant (p \< 0.05) increase of H3K9 tri-methylation (Tri-Met-H3-K9) (Figure [4A](#F4){ref-type="fig"}), supporting the acquisition of a repressive chromatin state \[[@B29]-[@B31]\].

Repressive histone modifications are often associated with aberrant hypermethylation at CpG islands present in the 5\' regulatory regions of many genes \[[@B32],[@B33]\] and references within). By using the CpG island searcher \[[@B34]\], a software for the identifying CpG islands, we could identify a CpG island only in the *Mgmt*promoter region \[[@B35]\] (Figure [4B](#F4){ref-type="fig"}). Bisulfite sequencing analysis of this region detected hypermethylation in AML1-MTG16-positive cells (Figure [4B](#F4){ref-type="fig"}).

The overall epigenetic analysis indicates that downregulation of AML1-targets by AML1-MTG16 can be achieved, even in the absence of DNA methylation, when there is a critical quantitative level of repressive histone changes.

Discussion
==========

In this study we show the effectiveness of integrating global gene expression array analysis with a bioinformatic approach aimed at detecting AML1-consensus sequences for identifying novel putative direct AML1-targets downregulated by AML1-MTG16 in 32D cells. Downregulation of these genes is marked by a distinct repressive chromatin profile.

When we surveyed the 37 most significantly downregulated genes for the presence of the AML1-consensus motif(s) in the 10 Kb region encompassing the transcription start site, we closed on seventeen putative direct AML1-MTG16 targets. For five of these genes, *Fcer1a, Tcfec, Ptprcap, F2rl3*and *Mgmt*, which were among the most significantly downregulated, we were able to demonstrate, using ChIP analysis, the binding of both AML1 and AML1-MTG16 to the gene regions containing the AML1-motifs. Thus, our two-tier approach, combining gene expression array analysis with bioinformatic survey for transcription factor-consensus sequences, seems to be a powerful strategy for identifying transcription factor targets, which would otherwise be missed when using conventional gene expression array analysis alone.

The chromatin of the five downregulated genes, *Fcer1a, Tcfec, Ptprcap, F2rl3*, and *Mgmt*, was marked not only by significant levels of histone H4 hypoacetylation, but also by significant levels of repressive histone H3-K9 trimethylation, suggesting that AML1-MTG16 might induce the recruitment of both histone deacetylases \[[@B28]\] and histone methyltransferases. Apparently, a critical quantity of repressive histone modifications, even in the absence of CpG methylation, might *per se*be sufficient to \"lock in\" a transcriptionally downregulated state. In the case of *Mgmt*, which has a CpG island, it is instead possible that the accumulation of histone repressive changes preceded CpG hypermethylation \[\[[@B36]\], and references within\].

It is noteworthy that all the genes for which we demonstrated AML1-MTG16-induced epigenetic downregulation encode for functions relevant to either hematopoiesis and/or leukemogenesis. We would like to underline that downregulation of two of the genes that we identified might be relevant to AML1-MTG16-induced leukemogenesis. One of these genes is *Tcfec*, whose human counterpart encodes a transcription factor that induces the granulocyte colony stimulating factor receptor *G-CSFR*\[[@B23],[@B24]\]. Remarkably, *Tcfec*downregulation in A16 cells is paralleled by a significant downregulation of *G-csfr*(data not shown), indicating that AML1-MTG16 might have triggered a coordinated cascade of transcriptional downregulation, as we observed in other differentiation model systems \[[@B37],[@B38]\]. The second gene is *Mgmt*, encoding the DNA repair enzyme O6-Methylguanine-DNA-methyltransferase, which is frequently silenced and hypermethylated in leukemia \[[@B39]\]. *MGMT*epigenetic silencing is thought to lead to random mutations in cancer \[[@B40]\]. A recent study has shown that expression of different acute myeloid leukemia fusion proteins, including AML1-MTG8, leads to downregulation of several DNA repair genes \[[@B41]\]. Thus, the induction of a \"mutator phenotype\" might be a common consequence of leukemia fusion protein expression.

A few global gene expression studies on cells expressing exogenous AML1-MTG8 have been recently described \[[@B42]-[@B44]\]. Given the use of different cell systems, it is difficult to compare the differentially expressed genes in AML1-MTG16-positive 32D cells with the differentially expressed genes reported for AML1-MTG8. Nevertheless, we could identify a few gene families (e.g. S100 Calcium-binding proteins) that are similarly affected by both AML1-MTG8 and AML1-MTG16 even in different cell contexts. Extending our study to the comparison of the epigenetic signatures imposed by either exogenous AML1-MTG16 or exogenous AML1-MTG8 in the very same cell context (e.g. 32D cells) might enable us to narrow down additional critical epigenetic signatures consequent to t(8;21) and t(16;21) translocations.

Conclusion
==========

In this study, we show that AML1-MTG16, the leukemia fusion protein associated with the non-random chromosome translocation t(16;21)(q24;q22), can impose transcriptional downregulation marked by a distinct epigenetic signature at specific AML1-target sites in the genome. Thus, our findings further support the hypothesis that non-random genetic abnormalities can lead to non-random epigenetic changes in leukemia cells \[[@B19],[@B45]\].

Methods
=======

Cell cultures
-------------

Stable clones obtained from mouse myeloid 32D cells infected either with pLNCX2-AML1-MTG16 (A16 clones) or the empty vector pLNCX2 (mock clones) were previously described \[[@B19]\]. Two prototypic A16 clones and two prototypic mock clones were used in this study. Cells were maintained in the presence of 10 ng/ml of murine IL-3 (BD Biosciences, San Jose, CA, USA) in RPMI 1640 medium supplemented with 10% fetal calf serum, 1% antibiotics (penicillin/streptomycin), adjusting the cell density to 2 × 10^5^cells/ml daily. To induce granulocyte differentiation, cells were washed in RPMI medium, and IL-3 was replaced with 10 ng/ml human G-CSF (Amgen, Thousand Oaks, CA, USA). Differentiation was microscopically evaluated on cytospin preparations stained with May-Grünwald-Giemsa.

RNA extraction and microarray hybridization
-------------------------------------------

Total RNA was extracted with RNeasy mini kit (Qiagen, Hilden, Germany) and treated with DNase (Qiagen). Double stranded cDNA was generated from 5 μg RNA using Superscript ds cDNA synthesis kit (Invitrogen, Carlsbad, CA, USA) and T7-oligo(dT) primers. The cDNA was purified with GeneChip Sample Cleanup Module (Affymetrix, Santa Clara, CA, USA) and used to synthesize biotin-labeled cRNA with Enzo RNA transcript Labeling Kit (Enzo Life Science, Farmingdale, NY, USA). Purified cRNA was quantified by spectrophotometric methods and the concentration was adjusted in order to exclude the carryover of unlabeled RNA. 11 μg of cRNA were then fragmented in fragmentation buffer (Affymetrix) at 95°C for 35 minutes and hybridized for 16 h at 45°C onto MOE430A microarrays (Affymetrix). After washing and staining, the chips were scanned in a Hewett-Packard/Affymetrix scanner at 570 nm. For all the samples the 5\'/3\' ratios of *Gapdh*were 0.7 -- 0.9. In comparative experiments the scaling factor, noise and presence calls were similar. Gene expression data represent the average of two independent experiments.

Microarray data analysis
------------------------

The arrays were normalized by geometric mean intensity for each probe set and scaled using log2 transformation for further analysis. Comparison between the A16 and mock clones grown with either IL-3 or G-CSF was done using Spotfire Decision Site. This comparison generated a p-value from a t-test to statistically extract significant changes in mRNA expression levels between the groups. p-values \< 0.05 were considered significant. The null hypothesis is that the samples between the groups are derived from the same population i.e. there is no significant differential expression. The t-test looks at the variance within the groups as well as between them. To be considered significantly differentially expressed the variance had to be greater between than within the groups to a level of p \< 0.05. Ratios were generated by dividing the average of the unlogged control data by the average of the unlogged AML1-MTG16 data. Ratios were then portrayed as positive or negative fold change between A16 and mock. To confirm statistical significance of these ratios the differentially expressed genes had to satisfy an arbitrary cut-off ratio as well as having a p-value \< 0.05 (see Results section). Analysis of the protein networks was performed by using Ingenuity Pathways Analysis (Ingenuity Systems, Redwood City, CA), software able to identify molecular networks based on known functional or physical interactions among the proteins encoded by the differentially expressed genes.

Search of AML1-consensus sequence in differentially expressed genes
-------------------------------------------------------------------

The well-annotated genes differentially expressed in the A16 clone *versus*the mock clone either in the presence of IL-3 or G-CSF (p \< 0.01 and absolute fold change \>3) were searched for the AML1-consensus sequence \"5\'-TG(T/C)GGT-3\"\' in the 10 kb region surrounding the transcription initiation sites (from -5000 bp to +5000 bp) using an in-house built PERL script. A 400 bp sequence flanking the potential AML1-binding sites (200 bp on each side) was extracted and analyzed with MEME, which is a software package to discover motifs in groups of related DNA sequences \[[@B46]\], and with multiple sequence alignment to test whether additional conserved motifs in the surrounding regions could be identified and to assess the sequence conservation extending the potential AML1-binding sites.

Real-time RT-PCR
----------------

Total RNA was obtained using Trizol (Invitrogen), treated with DNase I (Ambion, Austin, TX, USA), retrotranscribed with SuperScript™ First-Strand Synthesis System (Invitrogen) and amplified by Real-time RT-PCR on an iCycler (Bio-Rad, Hercules, CA, USA) by using iQ SYBR Green Supermix (Bio-Rad) and primers specific for *γ actin*, *F2rl3*, *Fcer1a*, *Ptprcap*, *Tcfec*, and *Mgmt*(Table [4](#T4){ref-type="table"}). Transcript levels of the genes of interest were quantitated by the Delta-delta Ct method, using the house keeping gene *γ-actin*for normalization. The amplification efficiency, evaluated from the sample slopes, was similar for all the samples analyzed in the same experiment. Two independent experiments were performed in triplicate using two mock clones and two A16 clones. Significance was determined by using the Student t-test.

Quantitative chromatin immunoprecipitation (ChIP)
-------------------------------------------------

ChIP was performed using reagents purchased from Upstate (Charlottesville, VA, USA) following the manufacturer\'s protocol. AML1 and AML1-MTG16 binding was assessed by ChIP with antibodies against either the AML1 C-terminus (Santa Cruz Biotechnology, Santa Cruz, CA, USA), or the MTG16 C-terminus \[[@B28]\], respectively. Histone hallmarks of repressive chromatin were assessed by ChIP with antibodies against acetyl-histone H4 (Upstate) and trimethyl-K9 at histone H3 (Upstate). Control ChIPs were performed without the respective antibodies. The immunoprecipitated DNA was amplified by real-time PCR with primers specific for regions encompassing the AML1-consensus, the transcription start site, or a control region (Table [4](#T4){ref-type="table"}). The DNA relative enrichment was calculated by using the Delta-delta Ct method. The PCR signals obtained for each gene region were normalized to the PCR signal obtained from the input DNA (total chromatin fraction) and compared to a control region approximately 15 kb downstream of *F2rl3*transcription start site. Two independent experiments were performed in triplicate, and significance was calculated by using the Student t-test.

Bisulfite sequencing
--------------------

Genomic DNA was extracted with DNAzol (Invitrogen) according to the manufacturer\'s instructions. DNA was modified by sodium bisulfite treatment as previously described \[[@B47]\]. *Mgmt*CpG island was amplified by nested PCR by using the primers indicated in Table [4](#T4){ref-type="table"}. The PCR fragments were subcloned into pGEM-T (Promega, San Luis Obispo, CA, USA) and 20 clones for each PCR fragment were sequenced.
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###### Additional File 1

Evidence of functional AML1 haploinsufficiency in AML1-MTG16-expressing cells. This figure shows the Ingenuity Pathways Analysis of the global gene expression changes identified in AML1-MTG16-expressing cells.
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Figures and Tables
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![**Global gene expression analysis of AML1-MTG16-expressing cells**. **A**. The 32D cell model, comprising clones expressing the AML1-MTG16 protein (A16 clones) and control clones (\"mock\" clones), which do not express the fusion protein. **B**. A16 clones, differently from mock clones, do not undergo granulocytic differentiation and display an impaired proliferation in the presence of G-CSF. **C**. Most of the genes whose expression is significantly affected in A16 cells were found previously implicated in biological processes.](1471-2164-8-38-1){#F1}

![**AML1-MTG16-induced downregulation of putative AML1-targets**. **A**. The AML1-consensus motif, containing the AML1-consensus sequence (framed), found by bioinformatic analysis of the genes significantly downregulated in A16 cells. The height of the columns associated with each nucleotide is proportional to the conservation level. The \"logo\" representation of the motif instead indicates in which proportion the single bases are present at each position. **B**. Seventeen out of the 37 downregulated genes are putative AML1-targets. The fold-changes of five of the most significantly downregulated genes are reported at right. **C**. Real time RT-PCR confirmed the significant (p \< 0.01) downregulation of the five genes.](1471-2164-8-38-2){#F2}

![**AML1-target gene validation**. **A**. Relative position of the AML1-consensus motifs (left) and their sequence (right) in the five putative AML1-target genes that were analyzed by ChIP. **B**. Quantitative ChIP analysis with antibodies either against AML1 or MTG16 showing a significant (p \< 0.05) enrichment of chromatin containing AML1-consensus motifs vs. chromatin containing a control region in AML1-MTG16-negative and AML1-MTG16-positive cells, respectively.](1471-2164-8-38-3){#F3}

![**Repressive epigenetic changes at the AML1-targets**. **A**. ChIP with antibodies against either acetylated histone H4 or tri-methylated histone H3 Lysine 9 (tri-Met-H3-K9) followed by quantitative PCR with primers amplifying a region encompassing either the transcription start site (+1) or the AML1-consensus detected a different level of repressive histone changes in all five genes in A16 cells. **B**. *In silico*analysis identified a CpG island only in the *Mgmt*promoter. This CpG island is hypermethylated in A16 cells (bottom, right).](1471-2164-8-38-4){#F4}

###### 

Selection of genes differentially expressed in AML1-MTG16-positive cells versus AML1-MTG16-negative cells grown in the presence of IL-3.

  **Affymetrix ID**   **NCBI acc. number**   **Gene Symbol**              **Gene Title**                                                                      **GO/Ingenuity annotations**                           **Fold change**
  ------------------- ---------------------- ---------------------------- ----------------------------------------------------------------------------------- ------------------------------------------------------ -----------------
  1450042_at          BB322201               *Arx*                        aristaless related homeobox gene (Drosophila)                                       regulation of transcription                            16.4
  1460300_a\_at       NM_008523              *Ltk*                        leukocyte tyrosine kinase                                                           kinase signaling pathway                               15.9
  1423869_s\_at       AF349659               *Txnrd3*                     thioredoxin reductase 3                                                             electron transport                                     12.9
  1418796_at          NM_009131              *Scgf*                       stem cell growth factor                                                             cell adhesion/cell proliferation                       9.6
  1427329_a\_at       AI326478               *Igh-6*                      immunoglobulin heavy chain 6 (heavy chain of IgM)                                   immune response                                        8.6
  1418588_at          NM_009513              *Vmp*                        vesicular membrain protein p24                                                      \-\--                                                  7.4
  1450652_at          NM_007802              *Ctsk*                       cathepsin K                                                                         proteolysis                                            7.2
  1428439_at          BG066220               *Nyren18-pending*            NY-REN-18 antigen                                                                   \-\--                                                  6.4
  1419416_a\_at       NM_011244              *Rarg*                       retinoic acid receptor, gamma                                                       regulation of transcription                            6.3
  1426800_at          BM214169               *D330025I23Rik (Cbfb)*       RIKEN cDNA D330025I23 gene (core-binding factor beta subunit)                       regulation of transcription                            6.2
  1419136_at          NM_134066              *Akr1c18*                    aldo-keto reductase family 1, member C18                                            electron transport                                     6.1
  1425432_at          AF260307               *Oprm*                       opioid receptor, mu                                                                 G-protein signaling pathway                            6.0
  1418346_at          NM_013754              *Insl6*                      insulin-like 6                                                                      physiological processes                                6.0
  1449426_a\_at       NM_011922              *Anxa10*                     annexin A10                                                                         \-\--                                                  5.9
  1423029_at          NM_008236              *Hes2*                       hairy and enhancer of split 2 (Drosophila)                                          regulation of transcription                            5.8
  1454007_a\_at       AK020384               *Zfp142*                     zinc finger protein 142                                                             electron transport                                     5.8
  1423313_at          BG070255               *Pde7a*                      phosphodiesterase 7A                                                                signal transduction                                    5.8
  1451915_at          L20509                 *Cct3*                       chaperonin subunit 3 (gamma)                                                        protein folding                                        5.7
  1452487_x\_at       BB133664               *Pirb*                       paired-Ig-like receptor B                                                           \-\--                                                  5.7
  1422030_at          AF326316               *Atp6v0a4*                   ATPase, H+ transporting, lysosomal V0 subunit A isoform 4                           ATP hydrolysis/proton transport                        5.6
  1427753_at          Z95479                 *Igh-4*                      immunoglobulin heavy chain 4 (serum IgG1)                                           immune response                                        5.5
  1437235_x\_at       BB218844               *Lpp*                        LIM domain containing preferred translocation partner in lipoma                     cytoskeleton organization/transcriptional regulation   5.4
  1426938_at          BB627486               *Nova1*                      neuro-oncological ventral antigen 1                                                 mRNA splicing                                          5.0
  1460416_s\_at       M55219                 *Csprs*                      component of Sp100-rs                                                               G-protein signaling pathway                            4.9
  1427884_at          AW550625               *Col3a1*                     procollagen, type III, alpha 1                                                      cell adhesion                                          4.9
  1450453_a\_at       NM_012065              *Pde6g*                      phosphodiesterase 6G, cGMP-specific, rod, gamma                                     vision                                                 4.8
  1455957_x\_at       AV034167               *Ceacam11*                   CEA-related cell adhesion molecule 11                                               \-\--                                                  4.7
  1450215_at          NM_009038              *Rcvrn*                      recoverin                                                                           vision                                                 4.7
  1452489_at          BC016258               *Vps11*                      vacuolar protein sorting 11 (yeast)                                                 protein transport                                      4.4
  1421705_at          NM_018732              *Scn3a*                      sodium channel, voltage-gated, type III, alpha polypeptide                          ion transport                                          4.4
  1421375_a\_at       NM_011313              *S100a6*                     S100 calcium binding protein A6 (calcyclin)                                         cell proliferation                                     4.4
  1433658_x\_at       AV300794               *Pcbp4*                      poly(rC) binding protein 4                                                          apoptosis                                              4.2
  1418136_at          NM_009365              *Tgfb1i1*                    transforming growth factor beta 1 induced transcript 1                              regulation of transcription                            4.2
  1450629_at          AV114522               *Eplin-pending*              epithelial protein lost in neoplasm                                                 \-\--                                                  3.9
  1455421_x\_at       AW490145               *Clcn1*                      chloride channel 1                                                                  ion transport                                          3.7
  1418451_at          BB522409               *Gng2*                       guanine nucleotide binding protein (G protein), gamma 2 subunit                     G-protein signaling pathway                            3.7
  1450709_at          NM_007851              *Defcr5*                     defensin related cryptdin 5                                                         defense response                                       3.5
  1423561_at          AI838010               *Nell2*                      nel-like 2 homolog (chicken)                                                        cell adhesion                                          3.4
  1452279_at          BB800282               *Pfc*                        properdin factor, complement                                                        complement activation                                  3.4
  1424531_a\_at       BC010807               *Tcea3*                      transcription elongation factor A (SII), 3                                          regulation of transcription                            3.4
  1419325_at          NM_019515              *Nmu*                        neuromedin                                                                          neuropeptide signaling pathway                         3.4
  1422945_a\_at       AI844677               *Kif5c*                      kinesin family member 5C                                                            protein transport                                      3.3
  1460280_at          NM_010815              *Mona*                       monocytic adaptor                                                                   intracellular signaling cascade                        3.3
  1448529_at          NM_009378              *Thbd*                       thrombomodulin                                                                      blood coagulation                                      3.2
  1449830_at          NM_013766              *Prlpi*                      prolactin-like protein I                                                            \-\--                                                  3.2
  1423596_at          BB528391               *Nek6*                       NIMA (never in mitosis gene a)-related expressed kinase 6                           kinase signaling pathway/cell proliferation            3.2
  1450435_at          NM_008478              *Slc7a2*                     solute carrier family 7 (cationic amino acid transporter, y+ system), member 2      amino acid transport                                   3.2
  1420373_at          BI249549               *Foxj2*                      forkhead box J2                                                                     regulation of transcription                            3.1
  1436769_at          AV101011               *Psma1*                      proteasome (prosome, macropain) subunit, alpha type 1                               ubiquitin-dependent protein catabolism                 3.1
  1421778_at          NM_011911              *V1rb2*                      vomeronasal 1, receptor B2                                                          chemosensory perception/G-protein signaling pathway    3.0
  **1448416_at**      **NM_008597**          ***Mglap***                  **matrix gamma-carboxyglutamate (gla) protein**                                     **\-\--**                                              **-3.0**
  **1419012_at**      **NM_011766**          ***Zfpm2***                  **zinc finger protein, multitype 2**                                                **regulation of transcription**                        **-3.0**
  **1449833_at**      **NM_011472**          ***Sprr2f***                 **small proline-rich protein 2F**                                                   **\-\--**                                              **-3.1**
  **1424814_a\_at**   **BC025541**           ***9030625M01Rik (Bclg)***   **RIKEN cDNA 9030625M01 gene (apoptosis regulator Bclg)**                           **apoptosis**                                          **-3.1**
  **1417338_at**      **U03487**             ***Epb4.2***                 **erythrocyte protein band 4.2**                                                    **structural function**                                **-3.3**
  **1448152_at**      **NM_010514**          ***Igf2***                   **insulin-like growth factor 2**                                                    **cell proliferation**                                 **-3.6**
  **1429947_a\_at**   **AK008179**           ***Zbp1***                   **Z-DNA binding protein 1**                                                         **\-\--**                                              **-3.7**
  **1420394_s\_at**   **U05264**             ***Gp49b***                  **glycoprotein 49 B**                                                               **immune response?**                                   **-3.7**
  **1424898_at**      **BC021154**           ***Slc10a1***                **solute carrier family 10 (sodium/bile acid cotransporter family), member 1**      **ion transport**                                      **-3.8**
  **1416822_at**      **BC013711**           ***Es2el***                  **expressed sequence 2 embryonic lethal**                                           **\-\--**                                              **-4.0**
  **1420779_at**      **NM_010213**          ***Fhl3***                   **four and a half LIM domains 3**                                                   **cytoskeleton organization**                          **-4.3**
  **1419124_at**      **NM_133829**          ***AW212394***               **expressed sequence AW212394**                                                     **\-\--**                                              **-4.4**
  **1425597_a\_at**   **AW060288**           ***Qk***                     **quaking**                                                                         **apoptosis**                                          **-4.6**
  **1422416_s\_at**   **NM_016983**          ***Vpreb2***                 **Pre-B lymphocyte gene 2**                                                         **hematopoiesis**                                      **-4.7**
  **1425863_a\_at**   **AF295638**           ***Ptpro***                  **protein tyrosine phosphatase, receptor type, O**                                  **phosphatase signaling pathway**                      **-4.8**
  **1418177_at**      **AF233778**           ***Gabrg2***                 **gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 2**                      **synaptic transmission**                              **-4.8**
  **1421309_at**      **NM_008598**          ***Mgmt***                   **O-6-methylguanine-DNA methyltransferase**                                         **DNA repair**                                         **-8.2**
  **1421288_at**      **NM_007975**          ***F2rl3***                  **coagulation factor II (thrombin) receptor-like 3**                                **blood coagulation/G-protein signaling pathway**      **-14.2**
  **1449347_a\_at**   **NM_021365**          ***Xlr4***                   **X-linked lymphocyte-regulated 4**                                                 **chromatin remodeling?**                              **-16.9**
  **1448511_at**      **NM_016933**          ***Ptprcap***                **protein tyrosine phosphatase, receptor type, C polypeptide-associated protein**   **phosphatase signaling pathway**                      **-17.7**
  **1421775_at**      **NM_010184**          **Fcer1a**                   **Fc receptor, IgE, high affinity I, alpha polypeptide**                            **signal transduction**                                **-27.2**

Limits: p-value \< 0.01; absolute fold change \> 3.

In bold are the AML1-MTG16-downregulated genes searched for AML1-consensus motifs.

###### 

Selection of genes differentially expressed in AML1-MTG16-positive cells versus AML1-MTG16-negative cells grown in the presence of G-CSF for 16 h.

  **Affymetrix ID**   **NCBI acc. number**   **Gene Symbol**             **Gene Title**                                                                        **GO/Iingenuity annotations**                                               **Fold change**
  ------------------- ---------------------- --------------------------- ------------------------------------------------------------------------------------- --------------------------------------------------------------------------- -----------------
  1437100_x\_at       BB206220               *Pim3*                      proviral integration site 3                                                           kinase signaling pathway                                                    24.5
  1460300_a\_at       NM_008523              *Ltk*                       leukocyte tyrosine kinase                                                             kinase signaling pathway                                                    19.9
  1416257_at          NM_009794              *Capn2*                     calpain 2                                                                             proteolysis/cell migration                                                  17.7
  1417314_at          NM_008198              *H2-Bf*                     histocompatibility 2, complement component factor B                                   cell proliferation/complement activation                                    14.7
  1425380_at          AF331457               *Rasgrp4*                   RAS guanyl releasing protein 4                                                        intracellular signaling cascade                                             10.4
  1450322_s\_at       NM_011409              *Slfn3*                     schlafen 3                                                                            cell proliferation                                                          10.2
  1421793_at          NM_010198              *Fgf11*                     fibroblast growth factor 11                                                           signal transduction/cell proliferation                                      9.5
  1420348_at          NM_008499              *Lhx5*                      LIM homeobox protein 5                                                                regulation of transcription                                                 8.8
  1419605_at          NM_010796              *Mgl1*                      macrophage galactose N-acetyl-galactosamine specific lectin 1                         cell adhesion                                                               8.6
  1420360_at          NM_010051              *Dkk1*                      dickkopf homolog 1 (Xenopus laevis)                                                   signal transduction/apoptosis                                               6.7
  1425647_at          BG069740               *Rnf33*                     ring finger protein 33                                                                \-\--                                                                       6.4
  1434851_s\_at       AU015319               *Crb3*                      crumbs homolog 3 (Drosophila)                                                         intercellular junction assembly                                             6.1
  1427102_at          AF099975               *Slfn4*                     schlafen 4                                                                            cell proliferation                                                          5.9
  1437218_at          BM234360               *Fn1*                       fibronectin 1                                                                         cell adhesion                                                               5.5
  1417777_at          BC014865               *Ltb4dh*                    leukotriene B4 12-hydroxydehydrogenase                                                metabolism                                                                  5.5
  1419406_a\_at       NM_016707              *Bcl11a*                    B-cell CLL/lymphoma 11A (zinc finger protein)                                         T/B-cell differentiation/corepressor                                        5.5
  1418358_at          NM_008574              *Mcsp*                      mitochondrial capsule selenoprotein                                                   sperm motility                                                              5.4
  1450499_at          NM_009124              *Sca1*                      spinocerebellar ataxia 1 homolog (human)                                              \-\--                                                                       5.2
  1418257_at          BB732135               *Slc12a7*                   solute carrier family 12, member 7                                                    ion transport                                                               5.1
  1424744_at          BC021950               *Sds*                       serine dehydratase                                                                    amino acid metabolism                                                       5.1
  1456305_x\_at       BB702568               *Obox1*                     oocyte specific homeobox 1                                                            regulation of transcription                                                 5.0
  1449707_at          C80272                 *Nr5a2*                     nuclear receptor subfamily 5, group A, member 2                                       regulation of transcription                                                 4.9
  1421504_at          NM_009239              *Sp4*                       trans-acting transcription factor 4                                                   regulation of transcription                                                 4.8
  1427079_at          U51204                 *Mapre3*                    microtubule-associated protein, RP/EB family, member 3                                cytoskeleton organization                                                   4.8
  1429626_at          AV024301               *Sftpa*                     surfactant associated protein A                                                       cell adhesion                                                               4.8
  1452793_at          AI509011               *Cldn10*                    claudin 10                                                                            cell adhesion                                                               4.7
  1419507_at          NM_013713              *Krtap15*                   keratin associated protein 15                                                         \-\--                                                                       4.7
  1421375_a\_at       NM_011313              *S100a6*                    S100 calcium binding protein A6 (calcyclin)                                           cell proliferation                                                          4.5
  1419517_at          NM_028408              *2900075G08Rik*             RIKEN cDNA 2900075G08 gene                                                            intracellular signaling cascade                                             4.4
  1454736_at          BM119297               *4921515A04Rik*             RIKEN cDNA 4921515A04 gene                                                            regulation of transcription                                                 4.3
  1436244_a\_at       AU067681               *Tle2*                      transducin-like enhancer of split 2, homolog of Drosophila E(spl)                     regulation of transcription/signal transduction                             4.2
  1420594_at          NM_007525              *Bard1*                     BRCA1 associated RING domain 1                                                        DNA repair/regulation of transcription/apoptosis                            4.2
  1426093_at          AF220141               *Trim34*                    tripartite motif protein 34                                                           \-\--                                                                       4.2
  1424748_at          BC021504               *Galnt11*                   UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11   metabolism                                                                  4.1
  1416855_at          BB550400               *Gas1*                      growth arrest specific 1                                                              cell cycle arrest///programmed cell death                                   4.0
  1422310_at          NM_009223              *Snn*                       stannin                                                                               \-\--                                                                       4.0
  1452463_x\_at       BG966217               *Igk-V8*                    immunoglobulin kappa chain variable 8 (V8)                                            immune response                                                             4.0
  1450415_at          NM_008805              *Pde6a*                     phosphodiesterase 6A, cGMP-specific, rod, alpha                                       signal transduction                                                         3.9
  1418792_at          AF326561               *Sh3gl2*                    SH3-domain GRB2-like 2                                                                \-\--                                                                       3.9
  1451759_at          BC013893               *Masp2*                     mannan-binding lectin serine protease 2                                               cell adhesion/complement activation                                         3.9
  1418921_at          AY059393               *Necl1-pending*             nectin-lke 1                                                                          cell adhesion                                                               3.9
  1416188_at          BC004651               *Gm2a*                      GM2 ganglioside activator protein                                                     sphingolipid metabolism                                                     3.8
  1448392_at          NM_009242              *Sparc*                     secreted acidic cysteine rich glycoprotein                                            cell proliferation                                                          3.8
  1419485_at          BB759833               *Foxc1*                     forkhead box C1                                                                       regulation of transcription                                                 3.7
  1419602_at          NM_010451              *Hoxa2*                     homeo box A2                                                                          regulation of transcription                                                 3.7
  1427358_a\_at       BC026671               *Dapk1*                     death associated protein kinase 1                                                     apoptosis                                                                   3.6
  1450827_at          NM_024245              *Kif23*                     kinesin family member 23                                                              mitosis                                                                     3.6
  1421280_at          Z36357                 *Gabra1*                    gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 1                            synaptic transmission                                                       3.5
  1452279_at          BB800282               *Pfc*                       properdin factor, complement                                                          complement activation                                                       3.5
  1415854_at          BB815530               *Kitl*                      kit ligand                                                                            cell proliferation/cell adhesion                                            3.4
  1417513_at          AI255184               *Evi5*                      ecotropic viral integration site 5                                                    \-\--                                                                       3.3
  1431379_a\_at       AK005153               *Slc13a1*                   solute carrier family 13 (sodium/sulphate symporters), member 1                       ion transport                                                               3.2
  1418476_at          NM_018827              *Crlf1*                     cytokine receptor-like factor 1                                                       \-\--                                                                       3.2
  1416009_at          NM_019793              *Tm4sf8-pending*            transmembrane 4 superfamily member 8                                                  signal transduction/cell proliferation                                      3.1
  **1451633_a\_at**   **BC025929**           ***Gng1***                  **guanine nucleotide binding protein (G protein), gamma 1 subunit**                   **G-protein signaling pathway**                                             **-3.0**
  **1425978_at**      **AF384055**           ***Srfcp-pending***         **SRF co-factor protein (cardiac and smooth muscle)**                                 **regulation of transcription/positive regulation of cell proliferation**   **-3.0**
  **1425153_at**      **BC008538**           ***Myh2***                  **myosin, heavy polypeptide 2, skeletal muscle, adult**                               **cytoskeleton organization**                                               **-3.1**
  **1448755_at**      **AF011450**           ***Col15a1***               **procollagen, type XV**                                                              **cell adhesion**                                                           **-3.2**
  **1433888_at**      **AV343478**           ***Atp2b2***                **ATPase, Ca++ transporting, plasma membrane 2**                                      **metabolism**                                                              **-3.5**
  **1426868_x\_at**   **AK003174**           ***Lmna***                  **lamin A**                                                                           **cell morphology**                                                         **-3.5**
  **1423292_a\_at**   **BG072867**           ***Prx***                   **periaxin**                                                                          **intracellular signaling cascade**                                         **-3.6**
  **1449891_a\_at**   **NM_028523**          ***Esdn-pending***          **endothelial and smooth muscle cell-derived neuropilin-like molecule**               **\-\--**                                                                   **-3.6**
  **1425708_at**      **AF285585**           ***Rnf17***                 **ring finger protein 17**                                                            **\-\--**                                                                   **-4.2**
  **1449836_x\_at**   **NM_007546**          ***Biklk***                 **Bcl2-interacting killer-like**                                                      **apoptosis**                                                               **-4.6**
  **1448710_at**      **D87747**             ***Cxcr4***                 **chemokine (C-X-C motif) receptor 4**                                                **defense response/hematopoiesis**                                          **-4.8**
  **1419227_at**      **NM_009839**          ***Cct6b***                 **chaperonin subunit 6b (zeta)**                                                      **protein folding**                                                         **-5.0**
  **1455853_x\_at**   **BB768303**           ***2700085A14Rik (Sas)***   **RIKEN cDNA 2700085A14 gene (Sarcoma amplified sequence)**                           **cell proliferation/signal transduction**                                  **-5.3**
  **1416822_at**      **BC013711**           ***Es2el***                 **expressed sequence 2 embryonic lethal**                                             **\-\--**                                                                   **-5.4**
  **1422473_at**      **BM246564**           ***Pde4b***                 **phosphodiesterase 4B, cAMP specific**                                               **signal transduction**                                                     **-7.8**
  **1418499_a\_at**   **NM_020574**          ***Kcne3***                 **potassium voltage-gated channel, Isk-related subfamily, gene 3**                    **ion transport**                                                           **-8.3**
  **1419537_at**      **NM_031198**          ***Tcfec***                 **transcription factor EC**                                                           **regulation of transcription**                                             **-20.6**
  **1449347_a\_at**   **NM_021365**          ***Xlr4***                  **X-linked lymphocyte-regulated 4**                                                   **chromatin remodeling?**                                                   **-34.4**

Limits: p-value \< 0.01; absolute fold change \> 3.

In bold are the AML1-MTG16-downregulated genes searched for AML1-consensus motifs.

###### 

Selection of putative AML1-target genes downregulated in AML1-MTG16-positive cells versus AML1-MTG16-negative cells.

  **Affymetrix ID**   **NCBI acc. number**   **Gene Symbol**       **Gene Title**                                                                  **GO/Ingenuity annotations**                    **Fold change IL-3**   **Fold change G-CSF**
  ------------------- ---------------------- --------------------- ------------------------------------------------------------------------------- ----------------------------------------------- ---------------------- -----------------------
  1417338_at          U03487                 Epb4.2                erythrocyte protein band 4.2                                                    structural function                             -3.3                   \-\--
  1433888_at          AV343478               Atp2b2                ATPase, Ca++ transporting, plasma membrane 2                                    metabolism                                      \-\--                  -3.5
  1426868_x\_at       AK003174               Lmna                  lamin A                                                                         cell morphology                                 \-\--                  -3.5
  1423292_a\_at       BG072867               Prx                   periaxin                                                                        intracellular signaling cascade                 \-\--                  -3.6
  1449891_a\_at       NM_028523              Esdn-pending          endothelial and smooth muscle cell-derived neuropilin-like molecule             \-\--                                           \-\--                  -3.6
  1425708_at          AF285585               Rnf17                 ring finger protein 17                                                          \-\--                                           \-\--                  -4.2
  1419124_at          NM_133829              AW212394              expressed sequence AW212394                                                     \-\--                                           -4.4                   \-\--
  1425597_a\_at       AW060288               Qk                    quaking                                                                         apoptosis                                       -4.6                   \-\--
  1419227_at          NM_009839              Cct6b                 chaperonin subunit 6b (zeta)                                                    protein folding                                 \-\--                  -5.0
  1455853_x\_at       BB768303               2700085A14Rik (Sas)   RIKEN cDNA 2700085A14 gene (Sarcoma amplified sequence)                         cell proliferation/signal transduction          \-\--                  -5.3
  1422473_at          BM246564               Pde4b                 phosphodiesterase 4B, cAMP specific                                             signal transduction                             \-\--                  -7.8
  1421309_at          NM_008598              *Mgmt*                O-6-methylguanine-DNA methyltransferase                                         DNA repair                                      -8.2                   \-\--
  1421288_at          NM_007975              F2rl3                 coagulation factor II (thrombin) receptor-like 3                                blood coagulation/G-protein signaling pathway   -14.2                  \-\--
  1449347_a\_at       NM_021365              Xlr4                  X-linked lymphocyte-regulated 4                                                 chromatin remodelling?                          -16.9                  -34.4
  1448511_at          NM_016933              Ptprcap (1)           protein tyrosine phosphatase, receptor type, C polypeptide-associated protein   phosphatase signaling pathway                   -17.7                  \-\--
  1419537_at          NM_031198              Tcfec                 transcription factor EC                                                         regulation of transcription                     \-\--                  -20.6
  1421775_at          NM_010184              Fcer1a                Fc receptor, IgE, high affinity I, alpha polypeptide                            signal transduction                             -27.2                  \-\--

Motif conservation significance: p \< 10E-5.

\(1\) The *Ptprcap*AML1-consensus motif is located in an intron of a 5\' adjacent gene (*Coro1b*).

###### 

Primers used for real time RT-PCR, quantitative ChIP, and bisulfite sequencing.

  **Primer name**                      **Orientation**   **Sequence**
  ------------------------------------ ----------------- ---------------------------------
  ***Real time PCR primers***                            
                                                         
  γ-Actin                              sense             5\'-GCCGGCTTACACTGCGCTTCTT-3\'
                                       antisense         5\'-TTCTGGCCCATGCCCACCAT-3\'
  F2rl3                                sense             5\'-GCTTCTGATCCTGGCAGCATG-3\'
                                       antisense         5\'-GTGTCACTGTCGTTGGCACAG-3\'
  Fcer1a                               sense             5\'-CCCTTTCCTGCTATGGGAACA-3\'
                                       antisense         5\'-GCAGCCAATCTTGCGTTACATT-3\'
  Ptprcap                              sense             5\'-GGATGAAGAGGATGCAGAAGAT-3\'
                                       antisense         5\'-CTGACTCCTATAGTGCAGTGAC-3\'
  Tcfec                                sense             5\'-AGTCTAATGATCCTGATATGCGC-3\'
                                       antisense         5\'-TCCTGAATCCGGAGCCTAAGC-3\'
  Mgmt                                 sense             5\'-GAACTTGGCAGAATGGCTGAG-3\'
                                       antisense         5\'-GGTGATGGAGAGCAGGCAA-3\'
                                                         
  ***ChIP primers***                                     
                                                         
  Ptprcap- AML1-consensus              sense             5\'-GTCCTGCAGCTGGTGTTTACAG-3\'
                                       antisense         5\'-CTGGTCTCTGAGTGGCTGCA-3\'
  Ptprcap-transcription start          sense             5\'-GAGGTCTGACAAGTTAGCTGTA-3\'
                                       antisense         5\'-ACCCTGTAACTCACTTCTCACT-3\'
  Tcfec- AML1-consensus                sense             5\'AGAGCTTGACTAGAATGGATTT-3\'
                                       antisense         5\'-GGTGCAACCCATTCATGGCTT-3\'
  Tcfec-transcription start            sense             5\'-AGTCACACCACTGGAGTAGTTTT-3\'
                                       antisense         5\'-CCCTCGTCTCATAACCTAAGCA-3\'
  Fcer1a- AML1-consensus               sense             5\'-GGCCACTGACTTCAGTGTGAA-3\'
                                       antisense         5\'-TGCATTCCAGTTCTCTGCAAGA-3\'
  Fcer1a-transcription start           sense             5\'-AGGTGTCAGCTGAAGGTACAATA-3\'
                                       antisense         5\'-CCCACCATGACACTCTCTAAAT-3\'
  F2rl3-AML1-consensus                 sense             5\'-AGGGTGTCTCTCTGAATCTGGA-3\'
                                       antisense         5\'-GGCAAGTCTGTTATCTCAGCAT-3\'
  F2rl3-transcription start            sense             5\'-TTGGAGGAAGGCTGGATTGTTAT-3\'
                                       antisense         5\'-CCCATTGGGATCTGCTTGCTCA-3\'
  Mgmt-AML1-consensus                  sense             5\'-GAGCTGCACACTGGGAAGATG-3\'
                                       antisense         5\'-GTGTACCAGATGCTGTGCAGG-3\'
  Mgmt-basic promoter                  sense             5\'-CAGTTTCAGGTCTGGAAGAAGAG-3\'
                                       antisense         5\'-AGCTGTGGGCTTGTAGTCCGAG-3\'
  Control region                       sense             5\'-ATGCAACACACAACAAAGCAAA-3\'
                                       antisense         5\'-GGCCAAATGAGGTTGTGTCCT-3\'
                                                         
  ***Bisulfite sequencing primers***                     
                                                         
  Mgmt-CpG-1^st^PCR                    sense             5\'-TAGTGATTGGATTTTTAGTGGGT-3\'
                                       antisense         5\'-CTATCTCCCTAAACTTCAACTC-3\'
  Mgmt-CpG-2^nd^PCR                    sense             5\'-GTGAGAAGGTGTAGTTTAGTTT-3\'
                                       antisense         5\'-CTCACCAACTTACAAACTACAA-3\'
